3-cyclopentyloxy-N-[3-[4-[(2,4-dioxoimidazolidin-1-yl)methyl]phenyl]-1-methylazetidin-3-yl]benzenesulfonamide

C25H30N4O5S — CID 146230429

IUPAC3-cyclopentyloxy-N-[3-[4-[(2,4-dioxoimidazolidin-1-yl)methyl]phenyl]-1-methylazetidin-3-yl]benzenesulfonamide
SMILESCN1CC(NS(=O)(=O)c2cccc(OC3CCCC3)c2)(c2ccc(CN3CC(=O)NC3=O)cc2)C1
InChIInChI=1S/C25H30N4O5S/c1-28-16-25(17-28,19-11-9-18(10-12-19)14-29-15-23(30)26-24(29)31)27-35(32,33)22-8-4-7-21(13-22)34-20-5-2-3-6-20/h4,7-13,20,27H,2-3,5-6,14-17H2,1H3,(H,26,30,31)
InChIKeyXZEGOGGNBVTCNO-UHFFFAOYSA-N
MW498.61 g/mol
LogP2.18
Rot. Bonds8

About 3-cyclopentyloxy-N-[3-[4-[(2,4-dioxoimidazolidin-1-yl)methyl]phenyl]-1-methylazetidin-3-yl]benzenesulfonamide

3-cyclopentyloxy-N-[3-[4-[(2,4-dioxoimidazolidin-1-yl)methyl]phenyl]-1-methylazetidin-3-yl]benzenesulfonamide (PubChem CID 146230429) has the molecular formula C25H30N4O5S and a molecular weight of 498.61 g/mol. Its IUPAC name is 3-cyclopentyloxy-N-[3-[4-[(2,4-dioxoimidazolidin-1-yl)methyl]phenyl]-1-methylazetidin-3-yl]benzenesulfonamide.

Molecular Properties

Compound Name3-cyclopentyloxy-N-[3-[4-[(2,4-dioxoimidazolidin-1-yl)methyl]phenyl]-1-methylazetidin-3-yl]benzenesulfonamide
PubChem CID146230429
Molecular FormulaC25H30N4O5S
Molecular Weight498.61 g/mol
Exact Mass498.19
IUPAC Name3-cyclopentyloxy-N-[3-[4-[(2,4-dioxoimidazolidin-1-yl)methyl]phenyl]-1-methylazetidin-3-yl]benzenesulfonamide
SMILESCN1CC(NS(=O)(=O)c2cccc(OC3CCCC3)c2)(c2ccc(CN3CC(=O)NC3=O)cc2)C1
InChIInChI=1S/C25H30N4O5S/c1-28-16-25(17-28,19-11-9-18(10-12-19)14-29-15-23(30)26-24(29)31)27-35(32,33)22-8-4-7-21(13-22)34-20-5-2-3-6-20/h4,7-13,20,27H,2-3,5-6,14-17H2,1H3,(H,26,30,31)
InChIKeyXZEGOGGNBVTCNO-UHFFFAOYSA-N
XLogP2.18
TPSA108.05 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms35
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500498.61
LogP ≤ 52.18
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze 3-cyclopentyloxy-N-[3-[4-[(2,4-dioxoimidazolidin-1-yl)methyl]phenyl]-1-methylazetidin-3-yl]benzenesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-cyclopentyloxy-N-[3-[4-[(2,4-dioxoimidazolidin-1-yl)methyl]phenyl]-1-methylazetidin-3-yl]benzenesulfonamide?
The IUPAC name of 3-cyclopentyloxy-N-[3-[4-[(2,4-dioxoimidazolidin-1-yl)methyl]phenyl]-1-methylazetidin-3-yl]benzenesulfonamide (CID 146230429) is 3-cyclopentyloxy-N-[3-[4-[(2,4-dioxoimidazolidin-1-yl)methyl]phenyl]-1-methylazetidin-3-yl]benzenesulfonamide.
What is the SMILES notation for 3-cyclopentyloxy-N-[3-[4-[(2,4-dioxoimidazolidin-1-yl)methyl]phenyl]-1-methylazetidin-3-yl]benzenesulfonamide?
The canonical SMILES for 3-cyclopentyloxy-N-[3-[4-[(2,4-dioxoimidazolidin-1-yl)methyl]phenyl]-1-methylazetidin-3-yl]benzenesulfonamide is CN1CC(NS(=O)(=O)c2cccc(OC3CCCC3)c2)(c2ccc(CN3CC(=O)NC3=O)cc2)C1.
What is the InChIKey of 3-cyclopentyloxy-N-[3-[4-[(2,4-dioxoimidazolidin-1-yl)methyl]phenyl]-1-methylazetidin-3-yl]benzenesulfonamide?
The InChIKey is XZEGOGGNBVTCNO-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H30N4O5S/c1-28-16-25(17-28,19-11-9-18(10-12-19)14-29-15-23(30)26-24(29)31)27-35(32,33)22-8-4-7-21(13-22)34-20-5-2-3-6-20/h4,7-13,20,27H,2-3,5-6,14-17H2,1H3,(H,26,30,31).
What are the key properties of 3-cyclopentyloxy-N-[3-[4-[(2,4-dioxoimidazolidin-1-yl)methyl]phenyl]-1-methylazetidin-3-yl]benzenesulfonamide?
3-cyclopentyloxy-N-[3-[4-[(2,4-dioxoimidazolidin-1-yl)methyl]phenyl]-1-methylazetidin-3-yl]benzenesulfonamide has a molecular weight of 498.61 g/mol, XLogP of 2.18, 8 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 3-cyclopentyloxy-N-[3-[4-[(2,4-dioxoimidazolidin-1-yl)methyl]phenyl]-1-methylazetidin-3-yl]benzenesulfonamide is sourced from PubChem (CID 146230429), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).